App-Quantinova.ai

Use of adjuvant radiotherapy in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Database study.

Nicholas Rydzewski - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The role of platinum rechallenge as second line chemotherapy for metastatic endometrial carcinoma.

Ronaldo Pereira Souza - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Evaluation of factors modifying endometrial cancer risk among women with Lynch syndrome: A cohort study.

Johanna Unelma Maenpaa - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

HAT1 as a target for the combination therapy with pazopanib and hyperthermia.

Chyong-Huey Lai - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Pazopanib

Chemotherapy under-dosing in obese endometrial cancer patients.

Ashley Ford Haggerty - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Carboplatin

Modified docetaxel, cisplatin and fluorouracil therapy as a first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.

Nebi Serkan Demirci - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Adrucil injection

The expression of programmed death ligand-1 (PD-L1) and use of PD-1 inhibitor-directed therapy with nivolomab in oral cavity cancer arising from recreational use of areca nut.

Michael Castro - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Erbitux

A HPV-18 positive NET of the uvula: Diagnosis and course of therapy in a 76 year old male patient.

Johannes Ehrich - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Solid malignancies

N/A

Bryan M Rabatic - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

p16 expression and its prognostic impact in HNSCC pts in Belem-Brazil.

Amanda Raquel da Silva Gomes - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Prognostic significance of perineural invasion in HPV (+) squamous cell oral and oropharyngeal carcinoma.

Justin Johnson - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Prognostic role of saliva mass spectrometry in the development of suppurative-septic complications after surgical treatment of oral mucosa cancer.

Aleksey Yurievich Maksimov - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Relationship between expression of hypoxia-inducible factor-1 and activity of transcription factors in patients with oral mucosa cancer.

Ekaterina Komarova - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Some parameters of the local immunity of patients with cancer of the oral mucosa and tongue.

Irina V. Aedinova - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Importance of -Catenin for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma.

Rui Jiang - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Induction chemotheraphy (IC) for locoregionally advanced head and neck cancer (LA-HNC): Experience at Instituto Oncologico Nacional SOLCA Guayaquil.

Katherine Garcia - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Histopathology correlation between depth of invasion and cervical lymph node metastasis in post operative patients of carcinoma buccal mucosa and tongue.

Dipti Rani Samanta - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Effect of radium 223 on remission of bone metastases in androgen receptor-positive (AR+) salivary duct carcinoma (SDC) of the parotid.

Mario Airoldi - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

CB-7598

Assessment of immune status of patients with locally advanced cancer of the upper jaw.

Marina Engibaryan - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Improved access to Childrens Oncology Group (COG) clinical trials for under-represented minorities and adolescents and young adults (AYAs) through a novel tri-institutional program: addressing cancer disparities.

Mario F Martinez - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Filters

41730 Abstracts